Rare diseases
Investigational molecules
Locations
5 Science Park, 06511-1966, United States
Research activity is centered on ER-positive, HER2-negative advanced or metastatic breast cancer, with attention to disease settings where endocrine-driven growth remains a major therapeutic concern.
The sponsor’s clinical focus in this area is aligned with treatment strategies for patients whose tumors depend on estrogen receptor signaling.
Arvinas Estrogen Receptor Inc. runs clinical trials in conditions such as Breast cancer metastatic, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
